These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3550623)

  • 1. [In vitro action of fosfomycin combined with rifampicin, pefloxacin and imipenem on staphylococci (checkerboard method in a liquid medium)].
    Quentin C; Noury P; Laurent C; Saivin S; Bebear C
    Pathol Biol (Paris); 1987 Feb; 35(2):153-7. PubMed ID: 3550623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
    Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
    Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Ishag AJ; Durgham SM; Shibl AM
    Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
    Fosse T; David MF; Duluc F; Darmusey D; Tamalet C; Toga B
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro study of the effects of an imipenem-fosfomycin combination against clinical strains of Staphylococcus].
    Fosse T; David MF; Duluc F
    Pathol Biol (Paris); 1986 Dec; 34(10):1055-9. PubMed ID: 3547260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synergy, addition, indifference, antagonism and dominance. Dominance and antibiotic combination].
    Drugeon HB; Dellamonica P; Caillon J
    Pathol Biol (Paris); 1987 May; 35(5):495-500. PubMed ID: 3302851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
    Pruekprasert P; Tunyapanit W
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro interactions between teicoplanin and other antibiotics against enterococci and staphylococci.
    Debbia E; Pesce A; Schito GC
    J Hosp Infect; 1986 Mar; 7 Suppl A():73-7. PubMed ID: 2871100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
    Zuccarelli M; Simeon de Buochberg M; Maillols M; Armynot du Chatelet AM; Attisso MA
    Pathol Biol (Paris); 1988 May; 36(5):403-9. PubMed ID: 3136422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin, and rifampin.
    Debbia E; Varaldo PE; Schito GC
    Antimicrob Agents Chemother; 1986 Nov; 30(5):813-5. PubMed ID: 2948444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy of fosfomycin with beta-lactam antibiotics against staphylococci and aerobic gram-negative bacilli.
    Chin NX; Neu NM; Neu HC
    Drugs Exp Clin Res; 1986; 12(12):943-7. PubMed ID: 3569007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
    Sahuquillo Arce JM; Colombo Gainza E; Gil Brusola A; Ortiz Estévez R; Cantón E; Gobernado M
    Rev Esp Quimioter; 2006 Sep; 19(3):252-7. PubMed ID: 17099793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antibacterial activity of imipenem against Pseudomonas and Staphylococcus species. Comparison with thirteen other antimicrobial agents.
    Cristiano P; Abbate GF; Alagia I; Leonessa V; Giaquinto E; Savioli L
    Drugs Exp Clin Res; 1985; 11(1):39-48. PubMed ID: 3869802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of fosfomycin against 'problem' gram-positive cocci.
    Hamilton-Miller JM
    Microbios; 1992; 71(287):95-103. PubMed ID: 1453987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro effect of combinations of netilmicin and amikacin with fosfomycin and pefloxacin on 31 strains of heterogeneous methicillin- resistant Staphylococcus aureus].
    David C; Chaste A; Saison C; Combremont AG
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):608-12. PubMed ID: 3054735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination between fosfomycin and oxacillin or cefotaxime against methicillin-resistant Staphylococci and Enterococci].
    Duez JM; Kohli E; Pechinot A; Tremeaux JC; Kazmierczak A
    Pathol Biol (Paris); 1983 Jun; 31(6):515-8. PubMed ID: 6308543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fosfomycin resistance in Staphylococcus saprophyticus and other species of coagulase-negative staphylococci].
    Loulergue J; Pinon G; Laudat P; Audurier A
    Ann Microbiol (Paris); 1984; 135A(2):239-47. PubMed ID: 6721325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro study of the pefloxacine-ceftriaxone combination against 18 strains of Acinetobacter].
    Berardi-Grassias L; Bigel ML; Macheboeuf F; Boisivon A; Chauvière P; Guiomar C
    Pathol Biol (Paris); 1986 May; 34(5):436-9. PubMed ID: 3534716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antistaphylococcal activity of pefloxacin alone and in combination with other antistaphylococcal drugs.
    Fass RJ; Helsel VL
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1457-60. PubMed ID: 3481244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of minocycline combined with fosfomycin against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Sun C; Falagas ME; Wang R; Karageorgopoulos DE; Yu X; Liu Y; Cai Y; Liang B; Song X; Liu Z
    J Antibiot (Tokyo); 2011 Aug; 64(8):559-62. PubMed ID: 21772306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.